John Militello's Net Worth
$1.51 Million
Who is John Militello?
John Militello has an estimated net worth of $1.51 Million. This is based on reported shares across multiple companies, which include ROCKET PHARMACEUTICALS, INC., and IMMUNE PHARMACEUTICALS INC.
SEC CIK
John Militello's CIK is 0001662170
Past Insider Trading and Trends
2023 was John Militello's most active year for acquiring shares with 15 total transactions. John Militello's most active month to acquire stocks was the month of January. 2023 was John Militello's most active year for disposing of shares, totalling 12 transactions. John Militello's most active month to dispose stocks was the month of January. 2024 saw John Militello paying a total of $125,500.00 for 50,727 shares, this is the most they've acquired in one year. In 2024 John Militello cashed out on 38,014 shares for a total of $690,521.71, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ROCKET PHARMACEUTICALS, INC. (RCKT) Snapshot price: $18.51
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.78% | -917.00 |
$16.63 | -$15,245.12 | 50.53K |
Oct 31
| |||
Form 4
| -2.03% | -1.06K |
$18.50 | -$19,688.26 | 51.45K |
Aug 16
| |||
Form 4
| -1.52% | -812.00 |
$23.02 | -$18,688.18 | 52.52K |
Jul 22
| |||
Form 4
| -1.98% | -1.08K |
$23.35 | -$25,194.65 | 53.33K |
May 16
| |||
Form 4
| -1.51% | -833.00 |
$22.87 | -$19,050.71 | 54.41K |
Apr 22
| |||
Form 4
| +156.72% | 33.72K |
$28.10 | -$69,978.96 | 55.24K |
Feb 14 - Mar 21
| |||
Form 4
|
—
|
0
|
$21.20 | -$172,950.00 | 21.52K |
Feb 29
| |||
Form 4
| +30.94% | 5.08K |
$29.84 | -$96,615.44 | 21.52K |
Feb 16
| |||
Form 4
| +61.76% | 6.27K |
—
|
—
| 16.43K |
Feb 14
| |||
Form 4
| -5.91% | -638.00 |
$27.20 | -$17,355.51 | 10.16K |
Jan 22
| |||
Form 4
| +17.22% | 1.59K |
—
|
—
| 10.8K |
Jan 18
| |||
Form 4
| +8.28% | 725 |
—
|
—
| 9.48K |
Nov 14
| |||
Form 4
| -6.05% | -564.00 |
$17.06 | -$9,622.97 | 8.76K |
Oct 20
| |||
Form 4/A
| +4.81% | 510 |
$19.06 | -$20,508.56 | 11.11K |
Feb 17 - Oct 18
| |||
Form 4
| -4.85% | -284.00 |
$15.47 | -$4,393.76 | 5.57K |
Aug 17
| |||
Form 4
| +10.17% | 725 |
—
|
—
| 7.85K |
Aug 14
| |||
Form 4
| -7.44% | -573.00 |
$19.03 | -$10,905.91 | 7.13K |
Jul 20
| |||
Form 4
| +25.93% | 1.59K |
—
|
—
| 7.7K |
Jul 18
| |||
Form 4
| -3.85% | -245.00 |
$21.38 | -$5,236.87 | 6.12K |
May 17
| |||
Form 4
| +12.86% | 725 |
—
|
—
| 6.36K |
May 14
| |||
Form 4
| -29.36% | -2.34K |
$18.65 | -$43,678.30 | 5.64K |
Apr 21
| |||
Form 4
| +394.30% | 6.36K |
—
|
—
| 7.98K |
Apr 18
| |||
Form 4
| -43.53% | -1.24K |
$19.06 | -$23,710.64 | 1.61K |
Feb 17
| |||
Form 4/A
|
∞
| 2.86K |
—
|
—
| 2.86K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6 - Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMMUNE PHARMACEUTICALS INC No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||